Aptadir Therapeutics raises EUR 40 million seed round with CDP Venture Capital backing

Aptadir Therapeutics closed a EUR 40 million seed round, described as Italy’s largest biotech seed round, with CDP Venture Capital participating via its Digital Transition Fund alongside lead investor 4BIO Capital.